Advisors to the Food and Drug Administration (FDA) are analyzing today whether they will offer the new booster vaccines against COVID-19, which have been modified to better adapt to the mutations of the coronavirus, in the fall.
This after Moderna and Pfizer laboratories tested updated injections against the contagious omicron variant.
Many experts say that the updated boosters promise at least a little more benefit. That, assuming that the virus does not undergo further modifications.
About half of Americans eligible for that first booster dose never received it.